Levin Capital Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.7M Buy
207,248
+148
+0.1% +$34.5K 3.84% 2
2025
Q4
$42.9M Sell
207,100
-307
-0.1% -$60.7K 3.7% 6
2025
Q3
$38.5M Sell
207,407
-85
-0% -$14.6K 3.48% 5
2025
Q2
$31.7M Sell
207,492
-881
-0.4% -$135K 3.08% 6
2025
Q1
$34.6M Sell
208,373
-4,799
-2% -$751K 3.65% 4
2024
Q4
$30.8M Buy
213,172
+1,390
+0.7% +$215K 2.92% 6
2024
Q3
$34.3M Sell
211,782
-260
-0.1% -$41.4K 3.28% 5
2024
Q2
$31M Sell
212,042
-1,041
-0.5% -$155K 3.23% 4
2024
Q1
$33.7M Buy
213,083
+63
+0% +$10K 3.36% 5
2023
Q4
$33.4M Sell
213,020
-1,498
-0.7% -$230K 3.6% 3
2023
Q3
$33.4M Sell
214,518
-5,630
-3% -$929K 3.98% 2
2023
Q2
$36.4M Sell
220,148
-3,065
-1% -$495K 4.14% 3
2023
Q1
$34.6M Sell
223,213
-1,460
-0.6% -$236K 4.29% 3
2022
Q4
$39.7M Sell
224,673
-149
-0.1% -$25.7K 5.33% 2
2022
Q3
$36.7M Sell
224,822
-7,314
-3% -$1.24M 4.97% 2
2022
Q2
$41.2M Sell
232,136
-7,219
-3% -$1.29M 4.87% 1
2022
Q1
$42.4M Sell
239,355
-2,359
-1% -$401K 4.09% 3
2021
Q4
$41.4M Sell
241,714
-2,342
-1% -$383K 3.86% 3
2021
Q3
$39.4M Sell
244,056
-225
-0.1% -$38.4K 3.94% 4
2021
Q2
$40.2M Sell
244,281
-825
-0.3% -$137K 4.1% 4
2021
Q1
$40.3M Sell
245,106
-5,410
-2% -$875K 4.29% 4
2020
Q4
$39.4M Sell
250,516
-3,305
-1% -$488K 4.41% 4
2020
Q3
$37.8M Buy
253,821
+2,747
+1% +$406K 4.95% 3
2020
Q2
$35.3M Sell
251,074
-20,027
-7% -$2.92M 4.85% 2
2020
Q1
$35.5M Sell
271,101
-3,250
-1% -$461K 5.74% 2
2019
Q4
$40M Buy
274,351
+2,684
+1% +$364K 3.99% 5
2019
Q3
$35.1M Sell
271,667
-375
-0.1% -$49.4K 3.88% 5
2019
Q2
$37.9M Buy
272,042
+13,205
+5% +$1.83M 3.74% 7
2019
Q1
$36.2M Sell
258,837
-1,112
-0.4% -$149K 4.06% 7
2018
Q4
$33.5M Sell
259,949
-84,226
-24% -$11.7M 0.74% 36
2018
Q3
$47.6M Sell
344,175
-170
-0% -$22.6K 0.82% 38
2018
Q2
$41.8M Sell
344,345
-82,042
-19% -$10.2M 0.72% 38
2018
Q1
$54.6M Sell
426,387
-9,028
-2% -$1.22M 0.99% 31
2017
Q4
$60.8M Sell
435,415
-1,825
-0.4% -$254K 1.03% 31
2017
Q3
$56.8M Sell
437,240
-582
-0.1% -$77.2K 0.96% 31
2017
Q2
$57.9M Sell
437,822
-8,946
-2% -$1.14M 1.01% 32
2017
Q1
$55.6M Buy
446,768
+6,960
+2% +$831K 0.99% 32
2016
Q4
$50.7M Sell
439,808
-36,941
-8% -$4.27M 0.87% 33
2016
Q3
$56.3K Sell
476,749
-33,890
-7% -$4.11M 0.83% 30
2016
Q2
$61.9M Sell
510,639
-4,255
-0.8% -$483K 1.12% 28
2016
Q1
$55.7M Sell
514,894
-102,646
-17% -$10.6M 1.01% 23
2015
Q4
$63.4M Sell
617,540
-22,398
-4% -$2.25M 1.11% 26
2015
Q3
$59.7M Buy
639,938
+55,517
+9% +$5.37M 1.02% 27
2015
Q2
$57M Sell
584,421
-5,363
-0.9% -$537K 0.84% 34
2015
Q1
$59.3M Buy
589,784
+580
+0.1% +$59K 0.89% 32
2014
Q4
$61.6M Sell
589,204
-127,442
-18% -$13.4M 0.93% 29
2014
Q3
$76.4M Sell
716,646
-49,095
-6% -$5.09M 1.16% 25
2014
Q2
$80.1M Sell
765,741
-14,040
-2% -$1.42M 1.24% 25
2014
Q1
$76.6M Sell
779,781
-2,085
-0.3% -$193K 1.28% 23
2013
Q4
$71.6M Sell
781,866
-6,535
-0.8% -$602K 1.15% 26
2013
Q3
$68.3M Sell
788,401
-5,948
-0.7% -$534K 1.17% 27
2013
Q2
$68.2M Buy
+794,349
New +$67.4M 1.23% 26

Other funds holding JNJ

Levin Capital Strategies's JNJ Position: Q1 2026 in Review

Levin Capital Strategies increased its Johnson & Johnson (JNJ) stake by 0.07% in Q1 2026, buying an estimated $34.5K and bringing the position to 207,248 shares worth $50.7M. The position accounts for 3.84% of the portfolio, ranked #2.

Levin Capital Strategies first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $80.1M in Q2 2014. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Levin Capital Strategies held 207,248 shares of Johnson & Johnson worth $50.7M as of Q1 2026.
  • Levin Capital Strategies bought 148 Johnson & Johnson shares in Q1 2026, an estimated $34.5K.
  • Johnson & Johnson made up 3.84% of Levin Capital Strategies's portfolio in Q1 2026, its #2 holding.
  • Levin Capital Strategies first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Levin Capital Strategies's Johnson & Johnson position peaked at $80.1M in Q2 2014.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Levin Capital Strategies's 13F filing for Q1 2026, filed 13 May 2026.